Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 35,891 | 1,887 | N/A | N/A |
| Marketable Securities | 188,743 | 0 | N/A | N/A |
| Receivables | 35 | 35 | N/A | N/A |
| TOTAL | $231,100 | $2,407 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,882 | 1,472 | N/A | N/A |
| Investments And Advances | 11,973 | 0 | 0 | 0 |
| Other Non-Current Assets | 14,395 | 100 | 0 | 0 |
| TOTAL | $30,250 | $1,572 | $N/A | $N/A |
| Total Assets | $261,350 | $3,979 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,087 | 5,191 | 0 | 0 |
| Accrued Expenses | 3,305 | 3,582 | N/A | N/A |
| Other current liabilities | N/A | 117 | N/A | N/A |
| TOTAL | $8,875 | $8,890 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 12,244 | 60,917 | 0 | 0 |
| TOTAL | $12,244 | $60,917 | $N/A | $N/A |
| Total Liabilities | $21,119 | $69,807 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 30,559 | N/A | N/A | N/A |
| Common Shares | 304 | 4 | N/A | N/A |
| Retained earnings | -107,205 | -64,072 | N/A | N/A |
| Other shareholders' equity | 43 | -2,511 | 0 | 0 |
| TOTAL | $240,231 | $-65,828 | $N/A | $N/A |
| Total Liabilities And Equity | $261,350 | $3,979 | $0 | $0 |